Recertify to Continue Prescribing Clozapine

Please see the FDA notice concerning Clozapine REMS program updates/deadline extensions.

A SINGLE new registry will streamline clozapine management.

We know clozapine is very effective for schizophrenia...but it's often a last resort due to neutropenia risk and its complex monitoring.

The new Clozapine REMS Program is now the ONLY registry available.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote